Celaid Therapeutics is pleased to announce that our CEO, Nobuyuki Arakawa, will be speaking at the MEDISO Seminar, "Overcoming the Challenges of Healthcare Startups – Vol. 24: Fundraising – Venture Capital Support and the Forefront of Company Creation," to be held on Wednesday, July 22, 2026, from 5:00 p.m. to 6:15 p.m. (JST).
MEDISO (Medical Innovation Support Office) is a healthcare startup support initiative operated by Japan's Ministry of Health, Labour and Welfare (MHLW). This seminar will focus on venture capital support for healthcare startups and will include an introduction to the AMED-Certified Venture Capital Program, followed by a panel discussion on how startups can effectively leverage venture capital support and the AMED-certified VC program.
＜Event Details＞
Date & Time: Wednesday, July 22, 2026, 5:00 p.m. – 6:15 p.m. (JST)
On-site networking session: 6:15 p.m. – 7:30 p.m. (JST) (on-site participants only)
Venue: Nihonbashi Life Science Hub (Hybrid: on-site and online)
Registration Fee: Free
Capacity: 100 on-site participants / 500 online participants
Registration Deadline: Tuesday, July 21, 2026, 5:00 p.m. (JST) (Advance registration required)
Registration: https://mri.lmsg.jp/form/13980/LP6EmbY8